title: Emerging Therapies in Severe Eosinophilic Asthma.
authors.affiliation: Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore.
authors.forename: Pee Hwee
authors.initials: PH
authors.lastname: Pang
authors.affiliation: Institute for Lung Health, NIHR Respiratory Biomedical Research Unit, Department of Infection, Immunity & Inflammation, University of Leicester and University Hospitals of Leicester NHS Trust, Leicester, UK. Electronic address: ceb17@le.ac.uk.
authors.forename: Christopher E
authors.initials: CE
authors.lastname: Brightling
mesh_terms: D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D011657:Pulmonary Eosinophilia / Q000150:complications*
chemical_list: D018927:Anti-Asthmatic Agents; D000911:Antibodies, Monoclonal